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Abstract Ligand-regulated nuclear receptors, such as es-
trogen receptors, glucocorticoid receptor, vitamin D recep-
tor, and peroxisome proliferator-activated receptors, belong
to the most widely studied and best understood transcrip-
tion factors. Therefore, the dynamic nature of transcrip-
tional regulation was observed first with different members
of the nuclear receptor superfamily, but is now also
extended to other transcription factors, such as nuclear
factor κB. Dynamic and in part cyclical processes were
observed on the level of translocation into the nucleus,
association with genomic binding sites, exchange of co-
regulators and chromatin modifiers, occurrence of chroma-
tin marks, and activities of RNA polymerase II resulting in
mRNA synthesis. In this review, we summarize recent
findings on the dynamic regulation of nuclear receptor
target genes in the chromatin context.
Abbreviations
3C chromosome conformation capture
CDKN1A cyclin-dependent kinase inhibitor 1A
ChIP chromatin immunoprecipitation
CoA co-activator
CoR co-repressor
ER estrogen receptor
FRAP fluorescence recovery after photobleaching
GR glucocorticoid receptor
HDAC histone deacetylase
IGFBP3 insulin-like growth factor binding protein
KAT histone acetyltransferase
KDM histone demethylase
KMT histone methyltransferase
Med mediator
PDK4 pyruvate dehydrogenase kinase 4
PPAR peroxisome proliferator-activated receptor
qPCR quantitative real-time PCR
VDR vitamin D receptor
Introduction
Transcriptional regulation is a central process for nearly all
physiological actions of prokaryotes and eukaryotes. In
eukaryotes the complex of genomic DNA and nucleo-
somes, referred to as chromatin, in most cases represses
gene transcription (Razin 1998), because it occludes
binding sites of DNA-binding proteins. Fundamental
decisions in development, such as terminal differentiation
of cells, are mediated by a long-lasting programming of
chromatin (reviewed in Mohn and Schubeler 2009).
However, the epigenetic landscape can also be highly
dynamic and lead to short-lived states, such as a response
of chromatin to stress signals (reviewed in Talbert and
Henikoff 2006). Epigenetic changes origin from reversible
post-translational modifications, such as acetylation and
methylation, of histone proteins that are directed by histone
acetyltransferases (KATs), histone deacetylases (HDACs),
histone methyltransferases (KMTs), and histone demethy-
lases (KDMs) associating with DNA-binding transcription
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DOI 10.1007/s00412-010-0283-8factors (reviewed in Narlikar et al. 2002). The “histone
code” consists of specific sets of histone modifications
which are associated with genes that are actively tran-
scribed or with those that are repressed (Jenuwein and Allis
2001; Turner 1991). Moreover, plasticity of chromatin is
induced by ATP-dependent remodeling complexes, which
rearrange the organization of the nucleosomes (reviewed in
Hager et al. 2000). These rapid changes in chromatin
activation make them permissive for an interference with
transcriptional regulation. Most of the dynamic nature of
transcriptional regulation was observed at the example of
nuclear receptors and their target genes (reviewed in
George et al. 2009; Metivier et al. 2006; Trotter and Archer
2007), on which we will focus in this review. However, the
principles discussed here may apply to many other if not all
eukaryotic transcription factors.
Nuclear receptors
The superfamily of nuclear receptors contains 48 human
members, most of which have the special property to be
activated by small lipophilic ligands in the size of cholesterol
(Nuclear Receptor Committee 1999). Nuclear receptors
modulate genes that affect processes as diverse as reproduc-
tion, development, inflammation, and general metabolism.
The subgroup of endocrine nuclear receptors bind their
specific ligands, which are the steroid hormones estradiol,
progesterone, testosterone, cortisol, and aldosterol, thyroid
hormones or the biologically active forms of the fat-soluble
vitamins A and D, all-trans retinoic acid, and 1α,25-
dihydroxyvitamin D3,w i t haK d of 1 nM or less (reviewed
in Chawla et al. 2001). In contrast, adopted orphan nuclear
receptors, such as peroxisome proliferator-activated receptors
(PPARs) and liver X receptors, bind to dietary lipids, such as
fatty acids and oxysterols, and xenobiotics in the micromolar
to millimolar concentration range (reviewed in Mohan and
Heyman 2003). Finally, orphan nuclear receptors have no
natural ligand and behave like normal transcription factors.
The anatomical distribution of nuclear receptors indicates
that some receptors have ubiquitous or widespread expres-
sion, such as PPARδ, glucocorticoid receptor (GR), and
estrogen receptors (ERs), whereas others, such as the vitamin
D receptor (VDR) have a more restricted distribution
(Bookout et al. 2006).
Recently published chromatin immunoprecipitation
(ChIP)-Seq studies reported genome-wide 5.000 to 10.000
binding sites per nuclear receptor (Nielsen et al. 2008;
Welboren et al. 2009), while microarrays showed some
tenfold less genes being primary target genes within the
same cell type (Bunger et al. 2007; Welboren et al. 2009).
Interestingly, the majority of these sites are distal to
promoters (Carroll et al. 2006), a characteristic probably
true for most transcription factors (reviewed in Farnham
2009). This suggests that the regulatory unit of a gene
involves multiple transcription factor binding sites at
various positions and that the spatial organization of the
unit is important to bring via DNA looping at least one
activated nuclear receptor protein close to the transcription
start site of the respective primary nuclear receptor target
gene.
Co-regulators
Nuclear receptors recruit positive and negative co-
regulatory proteins, referred to as co-activators (CoAs;
reviewed in Aranda and Pascual 2001) and co-repressors
(CoRs; reviewed in Burke and Baniahmad 2000), respec-
tively. In a simplified view of nuclear receptor signaling, in
the absence of ligand the nuclear receptor interacts with
CoR proteins, which in turn associate with HDACs leading
to a locally more compact chromatin packaging (reviewed
in Xu et al. 1999). The binding of ligand induces the
dissociation of CoRs and the association of CoAs (reviewed
in Leo and Chen 2000). Some CoAs have KAT activity or
are complexed with proteins harboring such activity and
this results in the net effect of local chromatin relaxation
(reviewed in Glass and Rosenfeld 2000). In a subsequent
step, nuclear receptors interact with a member of the
mediator (Med) complex, which builds a bridge to the
basal transcriptional machinery (Rachez et al. 1999). In this
way, ligand-activated nuclear receptors serve first as
adaptors between gene regulatory regions and the chroma-
tin modifying enzyme complexes and then as activators of
RNA polymerase II.
The switch between gene repression and activation is
more complex than a simple alternative recruitment of two
different regulatory complexes (Malinen et al. 2008). Most
co-regulators are co-expressed in the same cell type at
relatively similar levels, which raises the possibility of their
concomitant recruitment to a specific promoter. Moreover,
it is presently not clear, whether co-regulators already mark
in some cases active regulatory elements independent of
DNA-binding transcription factors or if they always require
active recruitment to target sites. Both aspects emphasize
that the spatio-temporal context, i.e., the nuclear organiza-
tion and the timing of the association of transcription
factors and their co-regulators, plays an important role in
controlling gene transcription.
Transcriptional dynamics
Most models of transcriptional regulation tend to be static
and place transcription factor binding sites into their center.
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associated DNA-binding transcription factors provide a
platform for highly dynamic events of rapid association and
dissociation of co-regulatory proteins. Kinetic descriptions
of transcriptional regulation were shown during the last
decade preferentially at the example of members of the
nuclear receptor superfamily (reviewed in Carlberg 2010).
The main techniques used to evaluate transcriptional
processes kinetically were ChIP assays, quantitative real-
time PCR (qPCR), chromosome conformation capture (3C)
assays, fluorescence recovery after photobleaching (FRAP)
and real-time, single live-cell imaging of fluorescent-tagged
transcription factors (reviewed in Metivier et al. 2006;
Stavreva et al. 2009). Please note that the molecular biology
methods ChIP, qPCR, and 3C have a resolution of several
minutes, whereas the biophysical methods FRAP and live-
cell imaging resolve events in the sub-second range.
Therefore, both type of methods provide different informa-
tions about the duration of a transcription cycle with ChIP,
qPCR, and 3C suggesting 30 to 60 min (Degenhardt et al.
2009; Metivier et al. 2003) and FRAP and live-cell imaging
indicating far less (reviewed in Hager et al. 2004; Phair et
al. 2004). The apparent discrepancy may be explained by
the fact that FRAP experiments mainly detect the bulk,
rapid, and potentially transient binding of factors, while
ChIP assays only detect productive associations of regula-
tory genomic regions with specific transcription factors.
However, presently there are too few studies published in
diverse systems, in order to allow a general conclusion.
Using time-resolved ChIP first, Shang et al. (2000)
demonstrated that several CoA proteins were recruited in a
cyclical fashion to the ER-responding chromatin region of
the human trefoil factor 1 (also called pS2) gene. However,
the master example of time-resolved monitoring of recruit-
ment and release of cohorts of co-regulatory complexes on
a single transcription factor binding site was provided by
Metivier and colleagues on the same chromatin region
(Metivier et al. 2003). The sequential and ordered recruit-
ment of ERα, RNA polymerase II, and many chromatin
factors, such as CoAs, CoRs, KATs, HDACs, KMTs, and
KDMs, define the direction of cycling. Similar observations
were made with the androgen receptor on the human
kallikrein 3 (also called PSA) gene (Kang et al. 2002), with
the thyroid hormone receptor on the human dio1 gene
(Sharma and Fondell 2002), with VDR on the human genes
24-hydroxylase (Kim et al. 2005; Väisänen et al. 2005),
CDKN1A (also called p21; Saramäki et al. 2009) and
insulin-like growth factor binding protein 3 (IGFBP3;
Malinen et al, unpublished results) and with PPARδ on
the human pyruvate dehydrogenase kinase 4 (PDK4) gene
(Degenhardt et al. 2009). All these examples show cyclical
association of co-regulators and in part also of the
respective nuclear receptor with a periodicity of 30 to
60 min. Interestingly, the more recently published reports
on CDKN1A, PDK4, and IGFBP3 in addition could
demonstrate cycling of the synthesis of mature mRNA.
Interestingly, periodic limitation of transcription is generat-
ed by clearing the chromatin region of transcription factors
and by recruiting of HDACs and HMTs. Moreover, the
DNA methylation pattern at CpG regions close to regula-
tory chromatin regions also showed cyclical changes
(Metivier et al. 2008). All this induces for a short time a
restrictive chromatin environment, which after a few
minutes is reversed and a new cycle starts.
Models of transcriptional cycling
In a first simplified analysis, transcriptional cycling
depends on stimulus availability, association, and dissoci-
ation of the transcription factor and its co-regulators and
finally their possible removal through proteasomal degra-
dation. Metivier and colleagues postulate that transcription-
ally productive cycles are rather slow, because the initiation
of transcription requires specific sequences of events to
occur, which are ordered, kinetic, and directional and
dependent on productive events that occur frequently from
many rapid, stochastic, transient, and unproductive associ-
ations of factors (Metivier et al. 2006). In fact, many
nuclear proteins rapidly but non-productively associate with
regulatory chromatin regions before a deterministic event
takes place. Such continuous scanning is essential for
transcription and is mirrored in the high mobility seen by
FRAP and live-cell imaging.
As an alternative, we recently introduced a model based
on stochastic modeling (Degenhardt et al. 2009), in which
we assume that at least 30 proteins and six irreversible (i.e.,
energy consuming) steps participate in each transcription
cycle. A recent publication indeed indicated that cycling
requires energy consumption (Coulon et al. 2010). In
principle, the recruitment and assembly of these complexes
could occur in a random fashion, in a partially random
fashion (partially determined order) or in a uniquely defined
sequential order. In addition, the complexes could be
preformed already in the solution of the nucleoplasm or
they assemble on the DNA. Based on physiologically
relevant protein concentrations, on/off rates, and equilibri-
um constants, we found that only the models based on
sequential or partially determined orders of transcription-
complex assembly produce outputs that are consistent with
the kinetics of our experimental observations. Per transcrip-
tion cycle our model distinguishes three phases (Fig. 1): (1)
an activation phase in which transcription factors and HATs
are recruited to the regulatory regions in order to locally
open chromatin, (2) an initiation phase in which Med
proteins loop to the RNA polymerase II binding at the
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(3) a deactivation phase where HDAC and CoR association
lead to chromatin condensation. Hierarchical clustering
analysis of the ChIP-association profiles of transcription
factors, co-regulators, and chromatin modifications on the
PDK4 gene confirmed this subdivision (Degenhardt et al.
2009). For the cycling of mRNA, the regulatory region of a
gene cycles between an active state, during which mRNA is
both synthesized and degraded, and an inactive state,
during which only mRNA degradation occurs (Fig. 1).
Our stochastic transcription model for single cells predicts
that on the population level the transcription cycles would
fade out 5 h after stimulation, which we confirmed in a
long-time course experiment of PDK4 mRNA accumula-
tion (Degenhardt et al. 2009).
Only bursty genes show cycling on mRNA level
Transcriptional cycling on mRNA level can be observed
only, if a gene fulfills two essential conditions: a bursty
transcription and a short half-life of the transcript. There-
fore, by far, not every gene will show cycling of its mRNA
levels. A burst of transcription is in most cases the result of
the activation of an inducible transcription factor, such as a
member of the nuclear receptor superfamily, having a
dominant role on the activation of the respective gene.
However, bursty transcription is a quite general phenome-
non involving a vast array of mechanisms, such as nuclear
translocation and oscillations of second messengers (Ca
2+,
cAMP; Cai et al. 2008; reviewed in Chubb et al. 2006). The
length of the initiation phase influences the size and
duration of a transcription burst and is modulated by
epigenetic changes of the involved chromatin regions. This
suggests that transcription bursts are cell- and gene-specific.
Only when the half-life of the induced mRNA transcript
is shorter than the periodicity of the cycling, i.e., in average
less than 60 min, there is within one transcription cycle
enough mRNA degradation, in order to observe cycling of
transcript levels (Fig. 1). This reduces the list of genes that
show transcriptional cycling to those that encode short-
lived regulatory proteins, such as transcription factors and
kinases. Moreover, in order to see transcriptional cycling
also on cell population level, cells have to be synchronized
in their individual cycles. The stimulation with a nuclear
receptor ligand was shown to be sufficient for a population
level synchronization of cells (Degenhardt et al. 2009;
Saramäki et al. 2009), although in some studies (Metivier et
al. 2003; Shang et al. 2000), a pre-treatment with the RNA
polymerase II inhibitor α-amanitin was applied.
Why do genes show transcriptional cycling?
The most obvious answer to this question is that transcrip-
tional cycling allows better control of gene transcription. A
gene can be silenced far quicker, when it has to confirm
every 60 min, if its transcription is still required, than
without this control mechanism. The transcription cycle can
be stopped in several ways, such as lack of the inducing
signal for the transcription factor or changes to the
chromatin activation status.
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Fig. 1 Model of transcriptional cycling. The model monitors the three
phases of transcriptional cycling, of which only the initiation phase
results in the synthesis of mRNA, while mRNA degradation occurs at
all phases. If a gene shows bursty transcription and the half-life of the
mRNA is short enough, this will result in cycling of mRNA levels as
schematically depicted in the graph. Please note that only the core
proteins of the respective complexes are shown, we assume that each
protein complex contains up to 30 components. Ac, Acetylated
histones; Me, methylated DNA (dark gray) or histones (light brown);
Pol II, RNA polymerase II; TF transcription factor
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with high mobility of transcription factors and their co-
regulators (Gorski et al. 2006). These proteins contact each
other and their specific chromatin binding sites only for a
relatively short time (Phair et al. 2004), which provides
transcriptional regulation with a stochastic component. This
is further extended by the rapidly changing epigenetic state
of the involved chromatin regions, as shown for cycling
CpG methylation in the regulatory region of the pS2 gene
(Metivier et al. 2008). Could therefore transcriptional
cycling be the expression of noisy transcription (reviewed
in Hager et al. 2009; Raj and van Oudenaarden 2008)?
Positive feedback processes are able to enhance noise,
while negative feedback mechanisms in most cases reduce
the effect of noise (Thattai and van Oudenaarden 2001).
Regular oscillations are a widespread phenomenon in cell
biology, including those in glycolysis (Richard et al. 1996),
calcium signaling (reviewed in Berridge 1993) and circa-
dian rhythms (reviewed in Carlberg 2000). They show
remarkable fidelity and, by this, resistance to noise.
Moreover, they are entrained by periodic exposure to
signals, but are capable of “free running” without any
external signals. In analogy, we assume that the phenomena
here described of transcriptional dynamics represent a
transcriptional clock, which is entrained by the stimulus
of the respective transcription factor, such as a ligand in
case of nuclear receptors.
Other forms of transcriptional dynamics
The action of reusable factors, such as transcription factors
and their co-regulators, and of the chromatin activation
status is intrinsically cyclic, since they act as catalysts or
scaffolds. Ensembles of such systems can subsequently
display synchronized cycles depending on the stochastic
distribution functions of their cycling time. For example,
low frequency stimulations of cells with tumor necrosis
factor induce cycling of the abundance of the transcription
factor nuclear factor κB in the nucleus (Ashall et al. 2009).
Moreover, pulsative exposure of cells with ultradian release
of cortisol stimulates transcriptional cycling of the nuclear
receptor GR (Stavreva et al. 2009). Interestingly, these
transcriptional cycles of GR are not observed, when its
synthetic ligand dexamethasone is used, which stabilizes
the receptor for longer periods than the natural ligand
cortisol (Stavreva et al. 2009). We made similar observa-
tions when using in constant, i.e., non-pulsative stimulation
experiments the potent synthetic VDR agonist Gemini.
Gemini failed to induce transcriptional cycling of the
human IGFBP3 gene, while the natural ligand does
(Malinen et al, unpublished results). These observations
may have implications for the therapeutic application of
synthetic nuclear receptor ligands and may explain some of
their side effects.
Conclusion
There is no doubt that transcriptional regulation is a
dynamic process. However, the impact of the cyclical
phenomena here discussed of transcription factor and co-
regulator association with regulatory chromatin regions are
not fully explored in their impact on transcriptional
regulation. In many cases the cycling of nuclear proteins
and chromatin activation stages will not translate into a
cycling of mRNA or protein levels, i.e., they may not have
any direct impact on a physiological function of the cell.
Nevertheless, the cycling of transcription factors may
represent an important control mechanism, for example in
controlling overshooting transcription. Moreover, in
attempts to modulate transcriptional regulation, for example
in the therapeutic application of nuclear receptor ligands,
such as rosiglitazone as PPARγ ligand in the therapy of
type 2 diabetes and the ER antagonist tamoxifen against
breast cancer, cyclical phenomena should be taken into
account since they can have a significant impact on the
outcome.
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